Pittsburgh, PA4 Active Studies

Melanoma Clinical Trials in Pittsburgh, PA

Find 4 actively recruiting melanoma clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,119
Enrolling

Recruiting Melanoma Studies in Pittsburgh

RecruitingPittsburgh, PANCT06697301

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab....

740 participants
Eikon Therapeutics
View Study Details
RecruitingPittsburgh, PANCT05655312

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluate...

264 participants
Perspective Therapeutics
View Study Details
RecruitingPittsburgh, PANCT04139902

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) Vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

The purpose of this study is to test the effects of anti-PI-1 inhibitor (TSR-042) or anti-PD-1/anti-TIM-3 combination (TSR-042 / TSR-022) in patients with operable melanoma....

62 participants
Diwakar Davar
View Study Details
RecruitingPittsburgh, PANCT05361174

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....

53 participants
Iovance Biotherapeutics, Inc.
View Study Details

About Melanoma Clinical Trials in Pittsburgh

Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.

There are currently 4 melanoma clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 1,119 participants. Research is being sponsored by Eikon Therapeutics, Perspective Therapeutics, Diwakar Davar and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Melanoma Clinical Trials in Pittsburgh — FAQ

Are there melanoma clinical trials in Pittsburgh?

Yes, there are 4 melanoma clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What melanoma treatments are being tested?

The 4 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.

Data updated March 2, 2026 from ClinicalTrials.gov